Here is a summary of my phone call of Terry this morning:

- The deal is not final, TSX requires the Company to disclose of any LOI as soon as it happens.

- Financing the deal is going to take a lot of thought. Terry thinks that from now till June, many options will open: equity at reasonable prices as the Company gets its US listing it can try getting funds from down south along with pitching equity to local brokers as well. However, the deal might be a Combo of debt and equity, as one of Alda’s directors (Eugene) is on the board of a financing Company and they will work together on nailing the best deal for Alda’s shareholders.

- The next round of Therapeutic development requires CAD600k, payable over a few months, so there is no conflict in going through this deal and no further dilution

- Terry believes that this deal is important for Alda on the short and long term.

o First on the short term it allows the Company to start producing their products directly, with full control over quality, meanwhile, they will use synergies to have one distribution network, which results in better GM% for the combined Company. Moreover, the deal will get Alda to generate more $$ and be less reliant on the market for any funding.

o Long term the deal will enable Alda to conduct its manufacturing for its therapeutic products and because the facility is FDA approved, this would save Alda 6 to 12 months (Please note that therapeutic products could take 3 years to happen if ever)

Finally, this is what I will be doing with my Alda shares. I will sell 60-70% of my holdings when they put their products on the shelves of some big chains. The balance will be my lucky ticket for a few years if/when Terry gets his product approved by the FDA.

MMN